MedPath

Exercise and dialysis

Not Applicable
Conditions
hemodialysis patients.
Encounter for adequacy testing for hemodialysis
Z49.31
Registration Number
IRCT20170510033909N11
Lead Sponsor
Islamic Azad University, Isfahan Branch (Khorasgan), Research Deputy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

At least three months on dialysis treatment
Complete patient consent to participate in this study

Exclusion Criteria

No history of stroke in the last three months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hematological indicators. Timepoint: At the beginning and end of 12 weeks of study. Method of measurement: It is measured by using the venous blood sample of the subjects and the hematology cell counter analyzer of BC model Mindray company made in Iran.
Secondary Outcome Measures
NameTimeMethod
The quality of dialysis. Timepoint: At the beginning and end of the study after 12 weeks. Method of measurement: Will be checked out by two laboratory indicators KT / V and URR. In the KT / V formula, the variable K means urea clearance (dialysis purification rate), T means dialysis time, and V indicates the volume of urea distribution, which is approximately equal to the total body water. The URR was calculated by the formula BUN1-BUN2 / BUN1, which is BUN1 urea before dialysis and BUN2 urea after dialysis.
© Copyright 2025. All Rights Reserved by MedPath